MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
Summary
Merck & Co., Inc. ($MRK) received a $156M definitive contract from HHS/ASPR for ERVEBO (Ebola vaccine) procurement over 10 years. This is a modest but stable revenue addition for Merck, reinforcing its role in biodefense.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Merck receives $156M for Ebola vaccine procurement over 10 years.
- 2.The contract is small relative to Merck's $60.1B revenue but provides predictable income.
- 3.No direct legislative connection; the contract is a standalone procurement action.
Market Implications
For $MRK, this contract adds a predictable ~$15.6M annual revenue, which is negligible compared to the company's $60.1B top line. However, it reinforces Merck's position in the vaccine and biodefense market, which could support long-term government relationships. No significant stock price movement is expected from this award alone.
⚡ Government Convergence
Active government convergence in this signal’s sector right now.
Over the last 90 days, 41 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 34 federal contracts, 5 procurement notices and 2 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- ContractTHE CHARLES STARK DRAPER LABORATORY, INC.: ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE OR · 2026-09-03
- ContractGIGAGEN INC: NEXT GEN RECOMBINANT POLYCLONAL ANTIBODY DISCOVERY PLATFORM FOR THE DEVELPMENT OF MEDICAL COUNTERMEASURES · 2026-09-03
- ContractICAHN SCHOOL OF MEDICINE AT MOUNT SINAI: BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DI · 2026-09-08
Full Analysis
The contract award to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. ($MRK), is for $156M to procure ERVEBO, the Ebola vaccine. The awarding agency is the Department of Health and Human Services' Office of Assistant Secretary for Preparedness and Response, indicating a biodefense and pandemic preparedness focus. The contract runs from 2024 to 2034, providing a decade-long revenue stream. Merck's FY2025 revenue was $60.1B, so the annualized value of ~$15.6M is less than 0.03% of revenue, making it a small but positive contributor. No related legislation directly ties to this contract; the listed bills are unrelated to Ebola or vaccine procurement. Supply chain beneficiaries are not specified, but potential subcontractors could include contract manufacturing organizations (CMOs) or raw material suppliers, though no specific publicly traded tickers are identified. Historically, biodefense contracts provide stable, recurring revenue for pharmaceutical companies with approved medical countermeasures, often leading to sustained government partnerships.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct award for ERVEBO (Ebola vaccine) procurement from HHS/ASPR.
Who must act
Department of Health and Human Services, Office of Assistant Secretary for Preparedness and Response to Merck Sharp & Dohme LLC (Merck & Co., Inc.)
What happens
$156M total contract value over 10 years, representing approximately $15.6M annualized revenue, or ~0.03% of Merck's FY2025 revenue of $60.1B.
Stock impact
Adds a predictable, long-term revenue stream for Merck's vaccine portfolio. While small relative to total revenue, it strengthens Merck's position in biodefense and pandemic preparedness, a strategic growth area.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
SHIONOGI INC: $156M Department of Health and Human Services Contract
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Contract Details
Recipient
MERCK SHARP & DOHME LLC
Award Amount
$156,033,983
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →